Literature DB >> 22802496

Precision manufacturing for clinical-quality regenerative medicines.

David J Williams1, Robert J Thomas, Paul C Hourd, Amit Chandra, Elizabeth Ratcliffe, Yang Liu, Erin A Rayment, J Richard Archer.   

Abstract

Innovations in engineering applied to healthcare make a significant difference to people's lives. Market growth is guaranteed by demographics. Regulation and requirements for good manufacturing practice-extreme levels of repeatability and reliability-demand high-precision process and measurement solutions. Emerging technologies using living biological materials add complexity. This paper presents some results of work demonstrating the precision automated manufacture of living materials, particularly the expansion of populations of human stem cells for therapeutic use as regenerative medicines. The paper also describes quality engineering techniques for precision process design and improvement, and identifies the requirements for manufacturing technology and measurement systems evolution for such therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802496     DOI: 10.1098/rsta.2011.0049

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  9 in total

Review 1.  On the genealogy of tissue engineering and regenerative medicine.

Authors:  Himanshu Kaul; Yiannis Ventikos
Journal:  Tissue Eng Part B Rev       Date:  2014-12-23       Impact factor: 6.389

Review 2.  A blueprint for translational regenerative medicine.

Authors:  James P K Armstrong; Timothy J Keane; Anne C Roques; P Stephen Patrick; Claire M Mooney; Wei-Li Kuan; Venkat Pisupati; Richard O C Oreffo; Daniel J Stuckey; Fiona M Watt; Stuart J Forbes; Roger A Barker; Molly M Stevens
Journal:  Sci Transl Med       Date:  2020-12-02       Impact factor: 17.956

Review 3.  The evolution of synthetic receptor systems.

Authors:  Janvie Manhas; Hailey I Edelstein; Joshua N Leonard; Leonardo Morsut
Journal:  Nat Chem Biol       Date:  2022-01-20       Impact factor: 16.174

4.  Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow.

Authors:  Marina Montali; Serena Barachini; Francesca M Panvini; Vittoria Carnicelli; Franca Fulceri; Iacopo Petrini; Simone Pacini
Journal:  Front Cell Dev Biol       Date:  2016-10-17

Review 5.  The Progression of Regenerative Medicine and its Impact on Therapy Translation.

Authors:  Erik Jacques; Erik J Suuronen
Journal:  Clin Transl Sci       Date:  2020-02-06       Impact factor: 4.689

6.  Insights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection.

Authors:  Enrico Ragni; Paola De Luca; Carlotta Perucca Orfei; Alessandra Colombini; Marco Viganò; Gaia Lugano; Valentina Bollati; Laura de Girolamo
Journal:  Cells       Date:  2019-04-23       Impact factor: 6.600

7.  Needle to needle robot-assisted manufacture of cell therapy products.

Authors:  Jelena Ochs; Mariana P Hanga; Georgina Shaw; Niamh Duffy; Michael Kulik; Nokilaj Tissin; Daniel Reibert; Ferdinand Biermann; Panagiota Moutsatsou; Shibani Ratnayake; Alvin Nienow; Niels Koenig; Robert Schmitt; Qasim Rafiq; Christopher J Hewitt; Frank Barry; J Mary Murphy
Journal:  Bioeng Transl Med       Date:  2022-08-06

Review 8.  Gene therapy approaches for equine osteoarthritis.

Authors:  Parvathy Thampi; R Jude Samulski; Joshua C Grieger; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Front Vet Sci       Date:  2022-09-28

9.  Automated image analysis with the potential for process quality control applications in stem cell maintenance and differentiation.

Authors:  David Smith; Katie Glen; Robert Thomas
Journal:  Biotechnol Prog       Date:  2015-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.